Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

398 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[German validation of the Acute Cystitis Symptom Score].
Alidjanov JF, Pilatz A, Abdufattaev UA, Wiltink J, Weidner W, Naber KG, Wagenlehner F. Alidjanov JF, et al. Among authors: naber kg. Urologe A. 2015 Sep;54(9):1269-76. doi: 10.1007/s00120-015-3873-5. Urologe A. 2015. PMID: 26113302 German.
Prevention of recurrent urinary tract infections.
Wagenlehner FM, Vahlensieck W, Bauer HW, Weidner W, Piechota HJ, Naber KG. Wagenlehner FM, et al. Among authors: naber kg. Minerva Urol Nefrol. 2013 Mar;65(1):9-20. Minerva Urol Nefrol. 2013. PMID: 23538307 Review.
Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis.
Naber KG, Llorens L, Kaniga K, Kotey P, Hedrich D, Redman R. Naber KG, et al. Antimicrob Agents Chemother. 2009 Sep;53(9):3782-92. doi: 10.1128/AAC.00837-08. Epub 2009 Jul 6. Antimicrob Agents Chemother. 2009. PMID: 19581455 Free PMC article. Clinical Trial.
Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
Naber KG, Allin DM, Clarysse L, Haworth DA, James IG, Raini C, Schneider H, Wall A, Weitz P, Hopkins G, Ankel-Fuchs D. Naber KG, et al. Int J Antimicrob Agents. 2004 Jun;23(6):596-605. doi: 10.1016/j.ijantimicag.2003.12.017. Int J Antimicrob Agents. 2004. PMID: 15194131 Clinical Trial.
398 results